PR Carroll
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 1
- Cancer survivorship and care 1
- Cancer Research top 5%
-
- Prostate Cancer Diagnosis and Treatment 8
- Prostate Cancer Treatment and Research 8
- Renal cell carcinoma treatment 2
- Immunology and Allergy top 5%
- Cell Biology top 10%
-
- Bladder and Urothelial Cancer Treatments 3
-
- Hormonal and reproductive studies 1
-
- Radiopharmaceutical Chemistry and Applications 1
PR Carroll
14 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 766
- Cancer Research 414
- Pulmonary and Respiratory Medicine 659
- Immunology and Allergy 92
- Cell Biology 168
Countries citing papers authored by PR Carroll
This map shows the geographic impact of PR Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PR Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PR Carroll more than expected).
Fields of papers citing papers by PR Carroll
This network shows the impact of papers produced by PR Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PR Carroll. The network helps show where PR Carroll may publish in the future.
Co-authorship network
The 25 scholars most cited alongside PR Carroll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 8 | |
| 2 | 2023 | 3 | |
| 3 | 2020 | 2 | |
| 4 | Germline testing in those at risk of prostate cancer. | 2019 | 4 |
| 5 | 2007 | 373 | |
| 6 | 2006 | 1 | |
| 7 | 2006 | 4 | |
| 8 | 2001 | 28 | |
| 9 | 2001 | 3 | |
| 10 | Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epitheliumbreakdown → | 2000 | 1219 |
| 11 | 1998 | 20 | |
| 12 | Radiation therapy for the management of biopsy proved local recurrence after radical prostatectomy. | 1998 | 50 |
| 13 | Endoscopic management of upper tract urothelial tumors. | 1997 | 12 |
| 14 | Use of prostate-specific antigen (PSA) and PSA density in the detection of stage T1 carcinoma of the prostate. | 1996 | 3 |
About PR Carroll
PR Carroll is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hepatology, Surgery and Cancer Research, having authored 14 papers that have together received 1.7k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (8 papers), Bladder and Urothelial Cancer Treatments (3 papers), Renal cell carcinoma treatment (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Hormonal and reproductive studies (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and Cancer survivorship and care (1 paper). The work is most often cited by research in Oncology (766 citations), Cancer Research (414 citations), Pulmonary and Respiratory Medicine (659 citations), Immunology and Allergy (92 citations) and Cell Biology (168 citations). PR Carroll has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Peter Hein, Cunha Gr, TD Tlsty, H.K. Tsai, Natalia Sadetsky, Anthony V. D’Amico, Gary D. Grossfeld, Joseph C. Presti, Katsuto Shinohara and Mack Roach. Their work appears in journals such as Urology, Value in Health, JNCI Journal of the National Cancer Institute, Journal of Clinical Oncology and Epidemiologic Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.